Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Aggregation of hydroxyapatite crystals

N M Hansen, R Felix, S Bisaz

    Biochimica Et Biophysica Acta
    |December 21, 1976
    PubMed
    Summary
    This summary is machine-generated.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    [Introduction to bisphosphonates. History and functional mechanisms].

    Der Orthopade·2007
    Same author

    Bisphosphonates in osteoporosis.

    European spine journal : official publication of the European Spine Society, the European Spinal Deformity Society, and the European Section of the Cervical Spine Research Society·2003
    Same author

    Surgical management of breast cancer in the elderly patient.

    American journal of surgery·2001
    Same author

    [The water softening action of a medicinal agent. The discovery of a new drug class].

    Pharmazie in unserer Zeit·2001
    Same author

    [Osteoclasts in the reticule. Molecular mechanisms of bisphosphonates].

    Pharmazie in unserer Zeit·2001
    Same author

    Microsatellite alterations detected in the serum of early stage breast cancer patients.

    Annals of the New York Academy of Sciences·2001
    Same journal

    Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    Molecular Basis of Disease Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    General Subjects Cumulative Contents.

    Biochimica et biophysica acta·2020
    Same journal

    Erratum to 'on the role of exchangeable hydrogen bonds for the kinetics of P680<sup>+·</sup> Q<sub>A</sub> <sup>-·</sup> formation and P680<sup>+·</sup> Pheo<sup>-·</sup> recombination in photosystem II' [Biochim. Biophys. Acta 1276 (1996) 35-44].

    Biochimica et biophysica acta·2019
    Same journal

    Oligomeric state of the light-harvesting complexes B800-850 and B875 from purple bacterium Rubrivivax gelatinosus in detergent solution.

    Biochimica et biophysica acta·2019
    Same journal

    Regulation of pigment content and enzyme activity in the cyanobacterium Nostoc sp. Mac grown in continuous light, a light-dark photoperiod, or darkness.

    Biochimica et biophysica acta·2019
    See all related articles

    This study developed a system to analyze hydroxyapatite crystal aggregation, identifying potent inhibitors like diphosphonates and glycosaminoglycans relevant to mineralization and pathological calcification.

    Area of Science:

    • Biomineralization
    • Crystal Growth
    • Pathological Calcification

    Background:

    • Hydroxyapatite is the primary mineral component of bone and teeth.
    • Dysregulation of hydroxyapatite formation is implicated in pathological calcification, including kidney stone formation.
    • Understanding factors influencing hydroxyapatite aggregation is crucial for both normal and pathological processes.

    Purpose of the Study:

    • To develop a system for studying hydroxyapatite crystal aggregation.
    • To investigate the effects of various factors, including ions, organic molecules, and glycosaminoglycans, on hydroxyapatite aggregation.
    • To assess the potential relevance of these findings to normal mineralization and pathological calcification.

    Main Methods:

    • Development of a system to monitor hydroxyapatite crystal aggregation.

    Related Experiment Videos

  • Systematic testing of various substances (metal ions, organic molecules, diphosphonates, glycosaminoglycans, urine) for their effect on aggregation.
  • Investigation of the role of lysozyme in modulating inhibition by certain substances.

    • Main Results:

    • Diphosphonates (e.g., disodium dichloromethylene diphosphonate) and glycosaminoglycans (heparin, hyaluronic acid) were potent inhibitors of hydroxyapatite aggregation.
    • Citrate and pyrophosphate showed moderate to strong inhibition.
    • Urine exhibited high inhibitory activity, with heparin's inhibition being sensitive to lysozyme, unlike hyaluronic acid, pyrophosphate, or urine.
    • Monophosphonates and certain divalent cations (Pb2+, Zn2+, Mg2+) had minimal effects.

    Conclusions:

    • The study identified several potent inhibitors of hydroxyapatite crystal aggregation, including diphosphonates and glycosaminoglycans.
    • These findings have implications for understanding normal biomineralization processes.
    • The identified inhibitors and their mechanisms may offer insights into preventing or treating pathological calcification, such as urinary stone formation.